ENHA
Enhanced Group Inc.
Enhanced Group Inc. (ENHA) Stock News
The latest ENHA headlines and market coverage — 1 recent story, updated throughout the day.
- Zacks Investment Research·
HALO Expands ENHANZE Collaboration & Licensing Deal With ARGX
Halozyme Therapeutics announced an expansion of its collaboration with argenx, increasing exclusive ENHANZE technology targets from six to eight. The deal includes milestone payments and royalties on product sales. Halozyme raised its 2026 revenue guidance to $1.84-$1.91 billion, driven by strong royalty growth from J&J's Darzalex and argenx's Vyvgart Hytrulo.